Skip to main content

2021 | OriginalPaper | Buchkapitel

A Multi-objective Multi-type Facility Location Problem for the Delivery of Personalised Medicine

verfasst von : Andreea Avramescu, Richard Allmendinger, Manuel López-Ibáñez

Erschienen in: Applications of Evolutionary Computation

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Advances in personalised medicine targeting specific sub-populations and individuals pose a challenge to the traditional pharmaceutical industry. With a higher level of personalisation, an already critical supply chain is facing additional demands added by the very sensitive nature of its products. Nevertheless, studies concerned with the efficient development and delivery of these products are scarce. Thus, this paper presents the case of personalised medicine and the challenges imposed by its mass delivery. We propose a multi-objective mathematical model for the location-allocation problem with two interdependent facility types in the case of personalised medicine products. We show its practical application through a cell and gene therapy case study. A multi-objective genetic algorithm with a novel population initialisation procedure is used as solution method.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Fußnoten
1
A temperature-controlled supply chain that maintains a product viable through decreases in temperature.
 
2
Code for both MOO algorithms is available at doi:​ 10.​5281/​zenodo.​4495163.
 
Literatur
1.
Zurück zum Zitat Abou-El-Enein, M., Elsanhoury, A., Reinke, P.: Overcoming challenges facing advanced therapies in the EU market. Cell Stem Cell 19(3), 293–297 (2016)CrossRef Abou-El-Enein, M., Elsanhoury, A., Reinke, P.: Overcoming challenges facing advanced therapies in the EU market. Cell Stem Cell 19(3), 293–297 (2016)CrossRef
2.
Zurück zum Zitat Ahmadi-Javid, A., Seyedi, P., Syam, S.S.: A survey of healthcare facility location. Comput. Oper. Res. 79, 223–263 (2017)MathSciNetCrossRef Ahmadi-Javid, A., Seyedi, P., Syam, S.S.: A survey of healthcare facility location. Comput. Oper. Res. 79, 223–263 (2017)MathSciNetCrossRef
3.
Zurück zum Zitat Ardjmand, E., Weckman, G.R., Park, N., Taherkhani, P., Manjeet, S.: Applying genetic algorithm to a new location and routing model of hazardous materials. Int. J. Prod. Res. 53, 916–928 (2015)CrossRef Ardjmand, E., Weckman, G.R., Park, N., Taherkhani, P., Manjeet, S.: Applying genetic algorithm to a new location and routing model of hazardous materials. Int. J. Prod. Res. 53, 916–928 (2015)CrossRef
5.
Zurück zum Zitat Bersenev, A., Kili, S.: Management of ‘out of specification’ commercial autologous CAR-T cell products. Cell Gene Therapy Insights 4(11), 1051–1058 (2018)CrossRef Bersenev, A., Kili, S.: Management of ‘out of specification’ commercial autologous CAR-T cell products. Cell Gene Therapy Insights 4(11), 1051–1058 (2018)CrossRef
6.
Zurück zum Zitat Bhattacharya, R., Bandyopadhyay, S.: Solving conflicting bi-objective facility location problem by NSGA II evolutionary algorithm. Int. J. Adv. Manuf. Technol. 51(1–4), 397–414 (2010)CrossRef Bhattacharya, R., Bandyopadhyay, S.: Solving conflicting bi-objective facility location problem by NSGA II evolutionary algorithm. Int. J. Adv. Manuf. Technol. 51(1–4), 397–414 (2010)CrossRef
7.
Zurück zum Zitat Burkholder, T.W., Hill, K., Hynes, E.J.C.: Developing emergency care systems: a human rights-based approach. Bull. World Health Organ. 97(9), 612–619 (2019)CrossRef Burkholder, T.W., Hill, K., Hynes, E.J.C.: Developing emergency care systems: a human rights-based approach. Bull. World Health Organ. 97(9), 612–619 (2019)CrossRef
9.
Zurück zum Zitat Deb, K., Pratap, A., Agarwal, S., Meyarivan, T.: A fast and elitist multi-objective genetic algorithm: NSGA-II. IEEE Trans. Evol. Comput. 6(2), 182–197 (2002)CrossRef Deb, K., Pratap, A., Agarwal, S., Meyarivan, T.: A fast and elitist multi-objective genetic algorithm: NSGA-II. IEEE Trans. Evol. Comput. 6(2), 182–197 (2002)CrossRef
10.
Zurück zum Zitat Doerner, K.F., Gutjahr, W.J., Nolz, P.C.: Multi-criteria location planning for public facilities in tsunami-prone coastal areas. OR Spectrum 31(3), 651–678 (2008)MathSciNetCrossRef Doerner, K.F., Gutjahr, W.J., Nolz, P.C.: Multi-criteria location planning for public facilities in tsunami-prone coastal areas. OR Spectrum 31(3), 651–678 (2008)MathSciNetCrossRef
11.
Zurück zum Zitat Eder, C., Wild, C.: Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption. J. Market Access Health Policy 7(1), 1600939 (2019)CrossRef Eder, C., Wild, C.: Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption. J. Market Access Health Policy 7(1), 1600939 (2019)CrossRef
13.
Zurück zum Zitat Ermak, G.: Emerging medical technologies. World Scientific (2016) Ermak, G.: Emerging medical technologies. World Scientific (2016)
14.
Zurück zum Zitat Farahani, R.Z., SteadieSeifi, M., Asgari, N.: Multiple criteria facility location problems: a survey. Appl. Math. Model. 34, 1689–1709 (2010)MathSciNetCrossRef Farahani, R.Z., SteadieSeifi, M., Asgari, N.: Multiple criteria facility location problems: a survey. Appl. Math. Model. 34, 1689–1709 (2010)MathSciNetCrossRef
16.
Zurück zum Zitat Hanley, P.J.: Fresh versus frozen: effects of Cryopreservation on CAR T Cells. Mol. Therapy 27(7), 1213–1214 (2019), ISSN 15250024 Hanley, P.J.: Fresh versus frozen: effects of Cryopreservation on CAR T Cells. Mol. Therapy 27(7), 1213–1214 (2019), ISSN 15250024
17.
Zurück zum Zitat Hiassat, A., Diabat, A., Rahwan, I.: A genetic algorithm approach for location-inventory-routing problem with perishable products. J. Manuf. Syst. 42, 93–103 (2017)CrossRef Hiassat, A., Diabat, A., Rahwan, I.: A genetic algorithm approach for location-inventory-routing problem with perishable products. J. Manuf. Syst. 42, 93–103 (2017)CrossRef
18.
Zurück zum Zitat Jarosławski, S., Toumi, M.: Sipuleucel-t (Provenge) - Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention. BioDrugs 29(5), 301–307 (2015)CrossRef Jarosławski, S., Toumi, M.: Sipuleucel-t (Provenge) - Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention. BioDrugs 29(5), 301–307 (2015)CrossRef
19.
Zurück zum Zitat Lander, E.S., Linton, L.M., Birren, B.: Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921 (2001)CrossRef Lander, E.S., Linton, L.M., Birren, B.: Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921 (2001)CrossRef
20.
Zurück zum Zitat Lopes, A.G., Noel, R., Sinclair, A.: Cost analysis of vein-to-vein CAR T-cell therapy: automated manufacturing and supply chain. Cell Gene Therapy Insights 6(3), 487–510 (2020)CrossRef Lopes, A.G., Noel, R., Sinclair, A.: Cost analysis of vein-to-vein CAR T-cell therapy: automated manufacturing and supply chain. Cell Gene Therapy Insights 6(3), 487–510 (2020)CrossRef
21.
Zurück zum Zitat Medaglia, A.L., Villegas, J.G., Rodríguez-Coca, D.M.: Hybrid biobjective evolutionary algorithms for the design of a hospital waste management network. Journal of Heuristics 15(2), 153–176 (2009)CrossRef Medaglia, A.L., Villegas, J.G., Rodríguez-Coca, D.M.: Hybrid biobjective evolutionary algorithms for the design of a hospital waste management network. Journal of Heuristics 15(2), 153–176 (2009)CrossRef
22.
Zurück zum Zitat Nematollahi, M., Hosseni-Motlagh, S.M., Heydari, J.: Economic and social collaborative decision-making on visit interval and service level in a two-echelon pharmaceutical supply chain. J. Clean. Prod. 142, 3956–3969 (2017)CrossRef Nematollahi, M., Hosseni-Motlagh, S.M., Heydari, J.: Economic and social collaborative decision-making on visit interval and service level in a two-echelon pharmaceutical supply chain. J. Clean. Prod. 142, 3956–3969 (2017)CrossRef
23.
Zurück zum Zitat Panch, S.R., et al.: Effect of cryopreservation on autologous chimeric antigen receptor T-Cell characteristics. Mol. Therapy 27(7), 1275–1285 (2019), ISSN 15250024 Panch, S.R., et al.: Effect of cryopreservation on autologous chimeric antigen receptor T-Cell characteristics. Mol. Therapy 27(7), 1275–1285 (2019), ISSN 15250024
24.
Zurück zum Zitat Papathanasiou, M.M., Stamatis, C., Lakelin, M., Farid, S., Titchener-Hooker, N., Shah, N.: Autologous CAR T-cell therapies supply chain: challenges and opportunities? Cancer Gene Ther. 27(10–11), 799–809 (2020)CrossRef Papathanasiou, M.M., Stamatis, C., Lakelin, M., Farid, S., Titchener-Hooker, N., Shah, N.: Autologous CAR T-cell therapies supply chain: challenges and opportunities? Cancer Gene Ther. 27(10–11), 799–809 (2020)CrossRef
25.
Zurück zum Zitat Pirabán, A., Guerrero, W.J., Labadie, N.: Survey on blood supply chain management: models and methods. Comput. Oper. Res. 112, 104756 (2019) Pirabán, A., Guerrero, W.J., Labadie, N.: Survey on blood supply chain management: models and methods. Comput. Oper. Res. 112, 104756 (2019)
26.
Zurück zum Zitat Quinn, C., Young, C., Thomas, J., Trusheim, M.: Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System. Value Health 22(6), 621–626 (2019)CrossRef Quinn, C., Young, C., Thomas, J., Trusheim, M.: Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System. Value Health 22(6), 621–626 (2019)CrossRef
27.
Zurück zum Zitat Rahmani, A., Mirhassani, S.: A hybrid Firefly-Genetic Algorithm for the capacitated facility location problem. Inf. Sci. 283, 70–78 (2014)MathSciNetCrossRef Rahmani, A., Mirhassani, S.: A hybrid Firefly-Genetic Algorithm for the capacitated facility location problem. Inf. Sci. 283, 70–78 (2014)MathSciNetCrossRef
28.
Zurück zum Zitat Redekop, W.K., Mladsi, D.: The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health 16(6), (2013) Redekop, W.K., Mladsi, D.: The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health 16(6), (2013)
29.
Zurück zum Zitat Alliance for Regenerative Medicine: Clinical Trials in Europe: Recent Trends in ATMP Development. Technical report ARM, October 2019 Alliance for Regenerative Medicine: Clinical Trials in Europe: Recent Trends in ATMP Development. Technical report ARM, October 2019
30.
Zurück zum Zitat Sexauer, A., Sandlund, J.T., Marcus, K.J.: Paediatric Leukemia and Lymphoma. In: Gunder’s & Tepper’s Clinical Radiation Oncology, pp. 1468–1476, Elsevier (2020) Sexauer, A., Sandlund, J.T., Marcus, K.J.: Paediatric Leukemia and Lymphoma. In: Gunder’s & Tepper’s Clinical Radiation Oncology, pp. 1468–1476, Elsevier (2020)
31.
Zurück zum Zitat Sinclair, A., Monge, M.: Measuring Manufacturing Cost and Its Impact on Organizations. BioProcess International, p. 36–44 (2010) Sinclair, A., Monge, M.: Measuring Manufacturing Cost and Its Impact on Organizations. BioProcess International, p. 36–44 (2010)
32.
Zurück zum Zitat Steliarova-Fourcher, E., Colombet, M., Ries, L., Moreno, F., Dolya, A., Bray, F., et. al.: International incidence of childhood cancer, 2001–2010: a population based registry study. Lancet Oncol. 18(6), 719–731 (2017) Steliarova-Fourcher, E., Colombet, M., Ries, L., Moreno, F., Dolya, A., Bray, F., et. al.: International incidence of childhood cancer, 2001–2010: a population based registry study. Lancet Oncol. 18(6), 719–731 (2017)
33.
Zurück zum Zitat Sun, W., Malvar, J., Sposto, R., Verma, A., et al.: Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia 32(11), 2316–2325 (2018)CrossRef Sun, W., Malvar, J., Sposto, R., Verma, A., et al.: Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia 32(11), 2316–2325 (2018)CrossRef
34.
Zurück zum Zitat Villegas, J.G., Palacios, F., Medaglia, A.L.: Solution methods for the bi-objective (cost-coverage) unconstrained facility location problem with an illustrative example. Ann. Oper. Res. 147(1), 109–141 (2006)MathSciNetCrossRef Villegas, J.G., Palacios, F., Medaglia, A.L.: Solution methods for the bi-objective (cost-coverage) unconstrained facility location problem with an illustrative example. Ann. Oper. Res. 147(1), 109–141 (2006)MathSciNetCrossRef
35.
Zurück zum Zitat Wang, B., Liang, Y., Zheng, T., Yuan, M., Zhang, H.: Multi-objective site selection optimization of the gas-gathering station using nsga-ii. Process Saf. Environ. Prot. 119, 350–359 (2018)CrossRef Wang, B., Liang, Y., Zheng, T., Yuan, M., Zhang, H.: Multi-objective site selection optimization of the gas-gathering station using nsga-ii. Process Saf. Environ. Prot. 119, 350–359 (2018)CrossRef
36.
Zurück zum Zitat Wang, X., Kong, Q., Papathanasiou, M.M., Shah, N.: Precision healthcare supply chain design through multi-objective stochastic programming. 13th International Symposium on Process Systems Engineering (PSE 2018) Computer Aided Chemical Engineering, p. 2137–2142 (2018) Wang, X., Kong, Q., Papathanasiou, M.M., Shah, N.: Precision healthcare supply chain design through multi-objective stochastic programming. 13th International Symposium on Process Systems Engineering (PSE 2018) Computer Aided Chemical Engineering, p. 2137–2142 (2018)
37.
Zurück zum Zitat Weiss, D., Rydland, H.T., Øversveen, E., Jensen, M.R., Solhaug, S., Krokstad, S.: Innovative technologies and social inequalities in health: A scoping review of the literature. PLoS One 13(4), e0195447 (2018) Weiss, D., Rydland, H.T., Øversveen, E., Jensen, M.R., Solhaug, S., Krokstad, S.: Innovative technologies and social inequalities in health: A scoping review of the literature. PLoS One 13(4), e0195447 (2018)
38.
Zurück zum Zitat Wilson, B., Nicholls, S.G.: The Human Genome Project, and recent advances in personalized genomics. Risk Management and Healthcare Policy, p. 9–20 (2015) Wilson, B., Nicholls, S.G.: The Human Genome Project, and recent advances in personalized genomics. Risk Management and Healthcare Policy, p. 9–20 (2015)
39.
Zurück zum Zitat Yang, L., Jones, B.F., Yang, S.H.: A fuzzy multi-objective programming for optimization of fire station locations through genetic algorithms. Eur. J. Oper. Res. 181(2), 903–915 (2007)CrossRef Yang, L., Jones, B.F., Yang, S.H.: A fuzzy multi-objective programming for optimization of fire station locations through genetic algorithms. Eur. J. Oper. Res. 181(2), 903–915 (2007)CrossRef
Metadaten
Titel
A Multi-objective Multi-type Facility Location Problem for the Delivery of Personalised Medicine
verfasst von
Andreea Avramescu
Richard Allmendinger
Manuel López-Ibáñez
Copyright-Jahr
2021
DOI
https://doi.org/10.1007/978-3-030-72699-7_25

Premium Partner